Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

Discover the Understanding (tumour-host interactions) Cluster projects through our video and brochure

The Understanding (tumour-host interactions) Cluster brings together six EU-funded projects – ARTURO, GLIOMATCH, HIT-GLIO, MULTIR, SPACETIME and THRIVE – to advance research on cancer development and contribute to Europe’s Beating Cancer Plan. Read more about the cluster and its project on our dedicated page.

Joint communication and dissemination

As part of the Communication and Dissemination working group, we’ve created joint cluster materials. Explore our new brochure and introductory video to learn more about the cluster’s objectives, collaboration areas and joint impact. 

Introductory video

Explore all videos on our dedicated page.

Cluster brochure (preview)

Download the full brochure and other project materials on our dedicated page.

Follow GLIOMATCH on LinkedIn and Facebook for more information on brain tumour research and updates on our milestones towards improving the clinical outcomes of GBM and pHGG.

For more pictures from our events, visit our photo gallery.

More Posts

GLIOMATCH: Explained with Prof. Dr. Sandra Jacobs

In this GLIOMATCH: Explained episode, Prof. Dr. Sandra Jacobs introduces the paediatric clinical study, the participating centres and the challenges of working with archived samples from paediatric high-grade glioma patients.

GLIOMATCH marks World Brain Tumour Day at EU event on advancing brain cancer research

On World Brain Tumour Day 2026, GLIOMATCH participated in the European event “Advancing Brain Cancer Research: From policy action to scientific breakthroughs” at the European Parliament in Strasbourg. The event highlighted the urgent need to accelerate brain cancer research, strengthen European collaboration and turn scientific progress into improved care for patients.

GLIOMATCH: Explained with Prof. Dr. Steven De Vleeschouwer

In this GLIOMATCH: Explained episode, Prof. Dr. Steven De Vleeschouwer introduces the prospective clinical trials, the participating centres and the immunotherapy strategies being investigated to better understand patient response in brain tumours.

GLIOMATCH 5th consortium meeting takes place in Barcelona

On 28–29 April 2026, the GLIOMATCH consortium gathered in Barcelona, Spain, for its fifth consortium meeting, hosted by project partner Sant Joan de Déu Barcelona Children’s Hospital and the Fundació de Recerca Sant Joan de Déu (FSJD).